Sōlaria Biō Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
15
- Latest Deal Type
-
M&A
Sōlaria Biō General Information
Description
Developer of a plant-sourced synbiotic medical food production platform designed to support bone health and address bone loss through the gut-bone axis. The company's medical food uses beneficial microbes naturally derived from edible plants and is designed to influence the gut-bone axis, enabling women with osteopenia to support bone density, reduce bone loss through a clinically studied, non-prescription approach, and lead a healthier life.
Contact Information
Website
www.solaria.bio(Operating Subsidiary)
Corporate Office
- 100 Beaver Street
- Waltham, MA 02453
- United States
Corporate Office
- 100 Beaver Street
- Waltham, MA 02453
- United States
Sōlaria Biō Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 01-Oct-2026 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 19-Nov-2025 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 09-Sep-2024 | Completed | Clinical Trials - General | |||
| 7. Accelerator/Incubator | Completed | Clinical Trials - General | ||||
| 6. Accelerator/Incubator | Completed | Clinical Trials - General | ||||
| 5. Grant | 23-Aug-2023 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series B) | 08-May-2023 | Completed | Startup | |||
| 3. Accelerator/Incubator | 27-Sep-2022 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 11-Sep-2020 | $11.3M | $11.5M | Completed | Startup | |
| 1. Accelerator/Incubator | 26-Jul-2017 | $200K | $200K | Completed | Startup |
Sōlaria Biō Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B3 | ||||||||
| Series B2 | ||||||||
| Series B | 12,390,905 | $0.000100 | $0.93 | $0.93 | 1x | $0.93 | 10.98% | |
| Series A | 19,898,765 | $0.000100 | $0.78 | $0.78 | 1x | $0.78 | 17.63% |
Sōlaria Biō Comparisons
Industry
Financing
Details
Sōlaria Biō Competitors (4)
One of Sōlaria Biō’s 4 competitors is Concerto Biosciences, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Concerto Biosciences | Venture Capital-Backed | Cambridge, MA | ||||
| Brightseed | Private Equity-Backed | South San Francisco, CA | ||||
| Seed Health | Venture Capital-Backed | Los Angeles, CA | ||||
| Pendulum | Venture Capital-Backed | San Francisco, CA |
Sōlaria Biō Patents
Sōlaria Biō Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026072827-A1 | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause in overweight and obese subjects | Pending | 26-Sep-2024 | ||
| AU-2022422001-A1 | Immunomodulatory compositions comprising microbial entities | Pending | 21-Dec-2021 | ||
| CA-3241760-A1 | Immunomodulatory compositions comprising microbial entities | Pending | 21-Dec-2021 | ||
| EP-4452287-A2 | Immunomodulatory compositions comprising microbial entities | Pending | 21-Dec-2021 | ||
| US-12016891-B2 | Immunomodulatory compositions comprising microbial entities | Active | 21-Dec-2021 | A61K35/747 |
Sōlaria Biō Signals
Sōlaria Biō Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AgeTech Collaborative from AARP | Accelerator/Incubator | |||
| BOLD Capital Partners | Venture Capital | Minority | ||
| GG 1978 | Venture Capital | Minority | ||
| GISEV Family Office | Family Office | Minority | ||
| Illumina Accelerator | Accelerator/Incubator | Minority |
Sōlaria Biō FAQs
-
When was Sōlaria Biō founded?
Sōlaria Biō was founded in 2017.
-
Where is Sōlaria Biō headquartered?
Sōlaria Biō is headquartered in Waltham, MA.
-
What is the size of Sōlaria Biō?
Sōlaria Biō has 15 total employees.
-
What industry is Sōlaria Biō in?
Sōlaria Biō’s primary industry is Drug Discovery.
-
Is Sōlaria Biō a private or public company?
Sōlaria Biō is a Private company.
-
What is Sōlaria Biō’s current revenue?
The current revenue for Sōlaria Biō is .
-
How much funding has Sōlaria Biō raised over time?
Sōlaria Biō has raised $37.4M.
-
Who are Sōlaria Biō’s investors?
AgeTech Collaborative from AARP, BOLD Capital Partners, GG 1978, GISEV Family Office, and Illumina Accelerator are 5 of 14 investors who have invested in Sōlaria Biō.
-
Who are Sōlaria Biō’s competitors?
Concerto Biosciences, Brightseed, Seed Health, and Pendulum are competitors of Sōlaria Biō.
-
When was Sōlaria Biō acquired?
Sōlaria Biō was acquired on 01-Oct-2026.
-
Who acquired Sōlaria Biō?
Sōlaria Biō was acquired by Viome Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process